COLLABORATIVE PUBLIC HEALTH STRATEGIES

QUESTION 1

TOPIC: COLLABORATIVE PUBLIC HEALTH STRATEGIES

Read the scenario, “A Message from the President” (SEE ATTACHMENT). Complete this assignment using the information in the briefing along with the assignment instructions. In the scenario, multiple agencies?at the state, local, and national levels?must work effectively for a concerted response. The gathered team includes:
? Public information officer.
? Director, Centers for Disease Control and Prevention.
? Director, Department of Homeland Security.
? Administrator, HAZMAT Operations.
? Director, FEMA.
You will choose ONE of these roles and respond according to the instructions for that particular role.
As you write your incident action plan, you will need to think about how your character’s role fits the group goal of preventing, minimizing, and preparing for a Chimera terrorist attack. You will answer your respective questions in a referenced, essay format. Be sure to address (in any role selected), some of the inherent leadership traits necessary to execute a response to this potentially devastating attack.
Public Information Officer
? Should the U.S. government inform citizens about the potential bioterrorist threat? Why or why not?
? What might be the government’s best course of action?
? Explain the issues relating to the use of Chimera (the components of) as a bio-weapon, about which the public should be educated.
? Historical aspects.
? Usual mode of infection.
? Transmission from person to person.
? Viability as a bio-weapon.
? Environmental considerations.
? What should a parent or educator tell children in the event of a bioterrorism attack?
? Should children be allowed to watch news shows? Why or why not?
? What means could be employed to prevent an attack before it occurs?
? Is it possible to develop a drug specialized to target the later stage of Chimera infection? Explain.
Director, Centers for Disease Control
? Describe the mechanism(s) of infection by Chimera.
? What method could health care workers utilize that would quickly circulate information about a possible bio-terror attack and would avert grave consequences?
? Briefly describe a plan for dealing with patients admitted to health care facilities after a bioterrorist attack using Chimera.
? How should health care providers protect themselves in the event of a Chimera attack?
? Would a vaccine be helpful in preventing the illness? Explain.
? How does genetic recombinant techniques factor into the public health response?
? What means could be employed to prevent an attack before it occurs?
? Is it possible to develop a drug specialized to target the later stage of Chimera infection? Explain.
Director, Department of Homeland Security
? Is a wide scale Chimera bioterrorism attack viable?
? How can Chimera be spread?
? What methods of Chimera dispersal are most effective in a bioterrorism attack?
? Identify signals that would indicate a possible act of Chimera biological terrorism.
? What critical infrastructures need to prepare for and respond to this event?
? What type of federal response resources will be necessary for effective response?
? What means could be employed to prevent an attack before it occurs?
? Is it possible to develop a drug specialized to target the later stage of Chimera infection? Explain.
Administrator, HAZMAT Operations
? What teams should be called in and what action should they take upon arrival?
? Who might be the first to recognize a bio-terror attack?
? What approaches can be used to clean up a Chimera bio-terror attack? Describe methods and effectiveness.
? What protective measures should HAZMAT personnel use for a probable Chimera bio-terror attack?
? Are protective measures necessary when working in the hot zone? Warm zone? Cold zone? What about working with infected humans?
? What means could be employed to prevent an attack before it occurs?
? Is it possible to develop a drug specialized to target the later stage of Chimera infection? Explain.
Director, FEMA
? What is the problem with conventional antibiotics in treating Chimera infections?
? What is weapon-grade Chimera?
? What makes inhalation of Chimera lethal?
? Describe a future device that may be used to identify a bio-terror agent.
? You realize that the current mode of treatment will not cure the initial masses of people that become infected with Chimera because by the time they show symptoms it is too late to treat. What research and agencies would help prevent a grave national disaster?
? Describe the various emergency support functions (ESFs) that would be engaged in this response.
? What means could be employed to prevent an attack before it occurs?
? Is it possible to develop a drug specialized to target the later stage of Chimera infection? Explain.
REFERENCES:

Text
Tibayrenc, Michel. Encyclopedia of Infectious Diseases: Modern Methodologies. Wiley-Liss (STMS), 07/2007. 9781118217108.

E-Books
Achord, J. L. (2002). Hepatitis B. In J. L. Achord, Understanding hepatitis (pp. 48?64). Jackson, MS: University Press of Mississippi.
Aggarwal, R. & Naik, S. (2008). Enterically transmitted hepatitis. In M. P. G. Koopmans, D. O. Cliver, & A. Bosch (Eds.), Food-borne viruses: Progress and challenges (pp. 65?85). Washington, DC: ASM Press.
Alic, M. (2013). Foodborne illness. In B. Narins (Ed.), The Gale encyclopedia of nursing and allied health (pp. 1381?1386). Detroit: Gale.
Chernin, J. (2000). Epidemiology. In J. Chernin, Parasitology (pp. 110?115). New York, NY: Taylor and Francis Routledge.
Cliver, D. O. (2008). Historic overview of food virology. In M. P. G. Koopmans, D. O. Cliver, & A. Bosch (Eds.), Food-borne viruses: Progress and challenges (pp. 1?28). Washington, DC: ASM Press.
Committee on Environmental Epidemiology. (1991). Air exposures. In Committee on Environmental Epidemiology, Environmental epidemiology: Volume 1: Public health and hazardous wastes (pp. 157?178). Washington, DC: National Academies Press.
Comstock, G. W. (2000). Epidemiology of tuberculosis. In L. B. Reichman & E. S. Hershfield (Eds.), Tuberculosis: A comprehensive international approach (2nd ed.) (pp. 117?142). New York, NY: Marcel Dekker.
Dennis, D. T. & Hayes, E. B. (2002). Epidemiology of lyme borreliosis. In J. Gray, O. Kahl, R. S. Lane, & G. Stanek (Eds.), Lyme borreliosis: Biology, epidemiology and control (pp. 251?280). Wallington, Oxon, GBR: CABI Publishing.
Fields, B. N. (1996). Pathogenesis of viral infections. In S. S. Morse (Ed.), Emerging viruses (pp. 69?78). Cary, NC: Oxford University Press.
Fong, I. W., & Kolia, M. (2003). MRSA in the 21st century: Emerging challenges. In I. W. Fong & K. Drlica (Eds.), Reemergence of established pathogens in the 21st century (pp. 99?154) . New York, NY: Kluwer Academic Publishers.
Grosset, J., Truffot-Pernot, C., & Cambau, E. (2000). Bacteriology of tuberculosis. In L. B. Reichman & E. S. Hershfield (Eds.), Tuberculosis: A comprehensive international approach (2nd ed.) (pp. 143?169). New York, NY: Marcel Dekker.
Hayes, E. B. & Schriefer, M. E. (2002). Vaccination against lyme borreliosis. In J. Gray, O. Kahl, R. S. Lane, & G. Stanek (Eds.), Lyme borreliosis: Biology, epidemiology and control (pp. 281?300). Wallington, Oxon, GBR: CAB International.
Healey, B. J. & Walker, K. T. ( 2009). Communicable diseases. In B. J. Healey & K. T. Walker, Introduction to occupational health in public health practice (pp. 199?214). Hoboken, NJ: Jossey-Bass.
Healey, B. J. & Walker, K. T. (2009). Occupational health disparities. In B. J. Healey & K. T. Walker, Introduction to occupational health in public health practice (pp. 233?257). Hoboken, NJ: Jossey-Bass.
Healey, B. J., & Walker, K. T. ( 2009). Stress. In B. J. Healey & K. T. Walker, Introduction to occupational health in public health practice (pp. 111?123). Hoboken, NJ: Jossey-Bass.
Hunter, P. R. (2009). Molecular epidemiology of Cryptosporidium and Giardia infections. In G. Ortega-Pierres, S. M. Cacci?, R. Fayer, T. G. Mank, H. V. Smith, & R. C. A. Thompson (Eds.)., Giardia and cryptosporidium: From molecules to disease (pp. 138?146). Wallington, Oxon, GBR: CAB International.
Kortbeek, L. M. (2009). Clinical presentation in Cryptosporidium-infected patients. In G. Ortega-Pierres, S. M. Cacci?, R. Fayer, T. G. Mank, H. V. Smith, & R. C. A. Thompson (Eds.)., Giardia and cryptosporidium: From molecules to disease (pp. 131?137). Wallington, Oxon, GBR: CAB International.
Lattanzi, M. & Rappuoli, R. (2004). Vaccination: Past, present, and future. In G. Grandi (Ed.), Genomics, proteomics, and vaccines (pp. 3?22). Hoboken, NJ: Wiley.
McNeill, W. H. (1996). Patterns of disease emergence in history. In S. S. Morse (Ed.), Emerging viruses (pp. 29?36). Cary, NC: Oxford University Press.
Mohammed, H. O. & Wade, S. E. (2009). The risk of zoonotic genotypes of Cryptosporidium spp. in watersheds. In G. Ortega-Pierres, S. M. Cacci?, R. Fayer, T. G. Mank, H. V. Smith, & R. C. A. Thompson (Eds.)., Giardia and cryptosporidium: From molecules to disease (pp. 123?130). Wallington, Oxon, GBR: CAB International.
Ryff, C. D. & Singer, B. H. (2001). Integrating emotion into the study of social relationships and health. In C. D. Ryff & B. H. Singer, Emotion, social relationships, and health (pp. 3?22). Cary, NC: Oxford University Press.
Seeman, T. (2001). How do others get under our skin? Social relationships and health. In C. D. Ryff & B. H. Singer, Emotion, social relationships, and health (pp. 189?220). Cary, NC: Oxford University Press.
Serruto, D., Rappuoli, R. & Pizza, M. (2004). Meningococcus B: From genome to vaccine. In G. Grandi (Ed.), Genomics, proteomics, and vaccines (pp. 185?204). Hoboken, NJ: Wiley.
Shope, R. E. & Evans, A. S. (1996). Assessing geographic and transport factors, and recognition of new viruses. In S. S. Morse (Ed.), Emerging viruses (pp. 109?119). Cary, NC: Oxford University Press.
Silman, A. J., & Macfarlane, G. J. (2002). Collecting information. In A. J. Silman & G. J. Macfarlane, Epidemiological studies (2nd ed.) (pp. 103?110). Port Chester, NY: Cambridge University Press.
Sockett, P. N. (2002). Food-borne diseases. In L. Breslow (Ed.), Encyclopedia of public health (pp. 452?455). New York: Macmillan Reference USA.
Stafford, K. C. & Kitron, U. (2002). Environmental management for lyme borreliosis control. In J. Gray, O. Kahl, R. S. Lane, & G. Stanek (Eds.), Lyme borreliosis: Biology, epidemiology and control (pp. 301?334). Wallington, Oxon, GBR: CABI Publishing.
Taylor, S. N. & Martin, D. H. (2007). Infections. In J. D. Klausner & E. W. Hook (Eds.), Current diagnosis and treatment of sexually transmitted diseases (pp. 69?137). Blacklick, OH: McGraw-Hill Medical Publishing Division.
Tibayrenc, M. (2007). Encyclopedia of infectious diseases: Modern methodologies. Hoboken, NJ: Wiley.
Note: The Encyclopedia of Infectious Diseases text is available electronically through the VitalSource Bookshelf. To access links this e-reading, go to your e-books pageon iGuide. You can find additional information about downloading e-books on this iGuide resource page.
Van-Tam, J. (2010). Seasonal influenza: Epidemiology, clinical features and surveillance. In Van-Tam, J., & Sellwood, C. (Eds.), Introduction to pandemic influenza (pp. 1?13). Wallington, Oxon, GBR: CABI Publishing.
Webber, R., (2005). Control principles and methods. In R. Webber, Communicable disease epidemiology and control: A global perspective (pp. 32?61). Wallington, Oxon, GBR: CABI International.
Webber, R., (2005). Control strategy and organization. In R. Webber, Communicable disease epidemiology and control: A global perspective (pp. 62?72). Wallington, Oxon, GBR: CABI International.
WHO Expert Committee on the Control of Chagas Disease. (2002). Control of Chagas disease: Second report of the WHO Expert Committee. Albany, NY: World Health Organization.
Articles
Library
The following required readings are provided to you in the Capella University Library. Ask a Librarian for assistance with any of these resources.
Barreto, M. L., Teixeira, M. G., & Carmo, E. H. (2006). Infectious diseases epidemiology. Journal of Epidemiology and Community Health, 60(3), 192?195.
De Vreese, L. (2009). Epidemiology and causation. Medicine, Health Care, and Philosophy, 12(3), 345?353.
Kramer, L. D., Li, J., & Shi, P-Y. (2007). West Nile virus. Lancet Neurology, 6(2), 171?181.
MacDonald, P. F. (2007). The MMR vaccine controversy?Winners, losers, impact and challenges. British Journal of Infection Control, 8(1), 18?22.
Internet
These required articles are available on the Internet. Please note that URLs change frequently. While the URLs were current when this course was designed, some may no longer be valid. If you cannot access a specific link, contact your instructor for an alternative URL. Permissions for the following links have been either granted or deemed appropriate for educational use at the time of course publication.
Arguin, P. M., Navin, A. W., Steele, S. F., Weld, L. H., & Kozarsky, P. E. (2004). Health communication during SARS. Emerging Infectious Diseases. Retrieved from https://www.cdc.gov/ncidod/EID/vol10no2/03-0812.htm
Centers for Disease Control & Prevention. (2010). STD/STI framing conversation report. Retrieved from www.cdc.gov/std/health-disparities/Framing_Report.pdf
Centers for Disease Control and Prevention. (2004). Steps of an outbreak investigation. Retrieved from https://www.cdc.gov/excite/classroom/outbreak/steps.htm
Monta?o, D. E., Kasprzyk, D., Carlin, L., & Freeman, C. (2005). HPV provider survey: Knowledge, attitudes, and practices about genital HPV infection and related conditions. Retrieved from https://www.cdc.gov/std/HP/HPVProviderSurveyExecSum.pdf
Morbidity and Mortality Weekly Report. (1982). A cluster of Kaposi’s sarcoma and pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange counties, California. Morbidity and Mortality Weekly Report. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/00001114.htm
Outbreak of severe acute respiratory syndrome?Worldwide, 2003. (2003). Morbidity and Mortality Weekly Report. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5211a5.htm
Optional
The following optional materials are offered to provide you with a better understanding of the topics in this course. These materials are not required to complete the course.
Optional Books
Use the Journal and Book Locator tool to see if the library has access to the book or the How Do I Find Books? library guide for additional options.
Sellwood, C. (2010). Brief history and epidemiological features of pandemic influenza. In Van-Tam, J., & Sellwood, C. (Eds.), Introduction to pandemic influenza (pp. 41?56). Wallington, Oxon, GBR: CABI Publishing.
PLACE THIS ORDER OR A SIMILAR ORDER WITH US TODAY AND GET AN AMAZING DISCOUNT 🙂